Update on Quality Topics for Herbal Drugs

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
The Herbal Medicinal Products Committee (HMPC) published the HMPC Work plan for 2022. Amongst others, the HMPC plans several activities relating to quality requirements for Herbal Medicinal Products (HMPs).
Quality Topics to be started in 2022
- Guideline on Good Agricultural and Collection Practice (GACP) of starting materials of herbal origin:
A concept paper on GACP revision has already been published. Following this, the HMPC will start drafting the revised GACP guideline taking into account responses received on the concept paper and publish the draft GACP guideline then for consultation.
- Questions & Answers (Q&As) on Quality of HMPs
The HMPC will remove Q&As now addressed in revised guidelines and add new ones collected / answered during past HMPC assessors’ trainings and meetings (e.g. on Elemental Impurities in HMPs, Skip Testing, Stability, GACP / GMP, Assay and Microbiological Issues).
- Guidance on New Manufacturing Techniques
A reflection paper is being developed addressing the absence of guidance on, for example, supercritical CO2-extracts.
- Guideline on Declaration of Herbal Substances and Herbal Preparations in HMPs
To elaborate on a more harmonized approach, a concept paper will be drafted for the revision of the guideline in response to new practices and experiences identified as well as new Ph. Eur. and EMA quality standards / guidelines.
- Reflection Paper on Markers used for Quantitative and Qualitative Analysis of HMPs
The HMPC will review Ph. Eur. definitions and HMPC monographs / assessment reports taking into account regulatory practice and different views on the role of active and analytical markers. A discussion paper is being drafted with proposals for better definitions considering existing Ph. Eur. defined extract types (particularly quantified extracts).
In addition, the HMPC announced to start with some activities relating to medical cannabis.
More information is available in EMA´s Committee on Herbal Medicinal Products (HMPC): work plan 2022 published on the HMPC website.
Related GMP News
02.04.2025BfArM Guideline for the Application for a Licence to Cultivate Cannabis
27.03.2025Can RWD support Medical Cannabis Evalution?
27.03.2025Omission of the German Cannabis Monograph
04.03.2025FDA requests Information on the Use of Cannabis Products in Animals
04.03.2025How to Classify Borderline Products?
30.01.2025FDA seeks Feedback on Opiate Alkaloid Content of Poppy Seeds